Publication Results

Generate Report

Add publications by marking their checkboxes, or

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.

Winchester DA,  Gurel B,  Till C,  Goodman PJ,  Tangen CM,  Santella RM,  Johnson-Pais TL,  Leach RJ,  Thompson IM,  Xu J,  Zheng SL,  Lucia MS,  Lippman SM,  Parnes HL,  Isaacs WB,  Drake CG,  De Marzo AM,  Platz EA
Prostate 2016 May;76(6):565-74
PubMed ID: 26771888
PMC ID: PMC4841624
Groups or Programs: Prostate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.

Murtola TJ,  Gurel B,  Umbehr M,  Lucia MS,  Thompson IM Jr,  Goodman PJ,  Kristal AR,  Parnes HL,  Lippman SM,  Sutcliffe S,  Peskoe SB,  Barber JR,  Drake CG,  Nelson WG,  De Marzo AM,  Platz EA
Cancer Epidemiol Biomarkers Prev 2016 Mar;25(3):463-9
PubMed ID: 26715424
PMC ID: PMC4779655
Groups or Programs: Prostate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets.

Shoemaker RH,  Suen CS,  Holmes CA,  Fay JR,  Steele VE
Semin Oncol 2016 Feb;43(1):189-197
PubMed ID: 26970137
PMC ID: PMC4789768
Groups or Programs: Chemopreventive Agent DevelopmentProstate and Urologic Cancer

A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.

Karzai FH,  Apolo AB,  Cao L,  Madan RA,  Adelberg DE,  Parnes H,  McLeod DG,  Harold N,  Peer C,  Yu Y,  Tomita Y,  Lee MJ,  Lee S,  Trepel JB,  Gulley JL,  Figg WD,  Dahut WL
BJU Int 2015 Oct;116(4):546-55
PubMed ID: 25407442
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.

Kumar NB,  Pow-Sang J,  Egan KM,  Spiess PE,  Dickinson S,  Salup R,  Helal M,  McLarty J,  Williams CR,  Schreiber F,  Parnes HL,  Sebti S,  Kazi A,  Kang L,  Quinn G,  Smith T,  Yue B,  Diaz K,  Chornokur G,  Crocker T,  Schell MJ
Cancer Prev Res (Phila) 2015 Oct;8(10):879-87
PubMed ID: 25873370
PMC ID: PMC4596745
Groups or Programs: Prostate and Urologic Cancer

Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.

Nash SH,  Till C,  Song X,  Lucia MS,  Parnes HL,  Thompson IM Jr,  Lippman SM,  Platz EA,  Schenk J
Cancer Epidemiol Biomarkers Prev 2015 Oct;24(10):1507-15
PubMed ID: 26269564
PMC ID: PMC4592455
Groups or Programs: Prostate and Urologic Cancer

Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients.

Okoro C,  George AK,  Siddiqui MM,  Rais-Bahrami S,  Walton-Diaz A,  Shakir NA,  Rothwax JT,  Raskolnikov D,  Stamatakis L,  Su D,  Turkbey B,  Choyke PL,  Merino MJ,  Parnes HL,  Wood BJ,  Pinto PA
J Endourol 2015 Oct;29(10):1115-21
PubMed ID: 25897467
PMC ID: PMC4593891
Groups or Programs: Prostate and Urologic Cancer

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Umbehr MH,  Gurel B,  Murtola TJ,  Sutcliffe S,  Peskoe SB,  Tangen CM,  Goodman PJ,  Thompson IM,  Lippman SM,  Lucia MS,  Parnes HL,  Drake CG,  Nelson WG,  De Marzo AM,  Platz EA
Prostate Cancer Prostatic Dis 2015 Sep;18(3):264-9
PubMed ID: 25939516
PMC ID: PMC4537352
Groups or Programs: Prostate and Urologic Cancer

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Winchester DA,  Till C,  Goodman PJ,  Tangen CM,  Santella RM,  Johnson-Pais TL,  Leach RJ,  Xu J,  Zheng SL,  Thompson IM,  Lucia MS,  Lippmann SM,  Parnes HL,  Dluzniewski PJ,  Isaacs WB,  De Marzo AM,  Drake CG,  Platz EA
Prostate 2015 Sep;75(13):1403-18
PubMed ID: 26047319
PMC ID: PMC4536102
Groups or Programs: Prostate and Urologic Cancer

Omeprazole alone, or in combination with Aspirin inhibits azoxymethane-induced colon adenoma progression to adenocarcinoma and carcinoma invasion in F344 rat model

Mohammed Altaf,  Patlolla Jagan M. R.,  Zhang Yuting,  Biddick Laura,  Madka Venkateshwar,  Li Qian,  Lightfoot Stan,  Lubel Ronald,  Suen Chen S.,  Steele Vernon E.,  Rao Chinthalapally V.
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 2820
PubMed ID: not available
PMC ID: not available
Groups or Programs: Chemopreventive Agent DevelopmentProstate and Urologic Cancer

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Winchester Danyelle A.,  Till Cathee,  Goodman Phyllis J.,  Tangen Catherine M.,  Santella Regina M.,  Johnson-Pais Teresa L.,  Leach Robin J.,  Xu Jianfeng,  Zheng S. Lilly,  Thompson Ian M.,  Lucia M. Scott,  Lippmann Scott M.,  Parnes Howard L.,  Dluzniewski Paul J.,  Isaacs William B.,  De Marzo Angelo M.,  Drake Charles G.,  Platz Elizabeth A.
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 4605
PubMed ID: not available
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.

Nash SH,  Schenk JM,  Kristal AR,  Goodman PJ,  Lucia MS,  Parnes HL,  Thompson IM,  Lippman SM,  Song X,  Gurel B,  De Marzo A,  Platz EA
Cancer Prev Res (Phila) 2015 Jul;8(7):590-6
PubMed ID: 25926387
PMC ID: PMC4491033
Groups or Programs: Prostate and Urologic Cancer

Pilot study on the bioactivity of vitamin d in the skin after oral supplementation.

Curiel-Lewandrowski C,  Tang JY,  Einspahr JG,  Bermudez Y,  Hsu CH,  Rezaee M,  Lee AH,  Tangrea J,  Parnes HL,  Alberts DS,  Chow HH
Cancer Prev Res (Phila) 2015 Jun;8(6):563-9
PubMed ID: 25835512
PMC ID: PMC4511849
Groups or Programs: Prostate and Urologic Cancer

Assessment of treatment response using Computed Tomography (CT) tumor volume measurements and lesion number in metastatic urothelial carcinoma (mUC) patients (pts) receiving cabozantinib.

Allette Kimaada,  Pattanayak Puskar,  Steinberg Seth M.,  Parnes Howard,  Jackson Gloria,  Francis Deneise,  Lamping Elizabeth,  Folio Les,  Apolo Andrea Borghese
J Clin Oncol 2015 May 20;33(15):Abstract e15503
PubMed ID: not available
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Evaluation of a new circulating tumor cell (CTC) platform to predict response and survival in metastatic urothelial carcinoma (UC) patients receiving cabozantinib (cabo).

Apolo Andrea Borghese,  Lee Min-Jung,  Tomita Yusuke,  Lee Sunmin,  Agarwal Piyush K.,  Jackson Gloria,  Francis Deneise C.,  Lamping Elizabeth,  Buford Lauren,  Tomita Saori,  Mackall Katherine,  Parnes Howard L.,  Dahut William L.,  Gulley James L.,  Trepel Jane B.
J Clin Oncol 2015 May 20;33(15):Abstract e15501
PubMed ID: not available
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Association of NaF PET/CT findings with PSA and alkaline phosphatase in untreated castration-sensitive prostate cancer.

Couvillon Anna,  Turkbey Baris,  Lindenberg Maria Liza,  Choyke Peter L.,  Kaushal Aradhana,  Citrin Deborah E.,  Krauze Andra V.,  McNally Deborah,  McKinney Yolanda,  Martinez Mirna,  Han Hui,  Karzai Fatima,  Parnes Howard L.,  Pinto Peter A.,  Gulley James L.,  Dahut William L.,  Madan Ravi Amrit
J Clin Oncol 2015 May 20;33(15):Abstract 122
PubMed ID: not available
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Effect of green tea catechins in prostate cancer chemoprevention.

Kumar Nagi B.,  Pow-Sang Julio,  Egan Kathleen,  Spiess Philippe E.,  Dickinson Shohreh I.,  Salup Raoul,  Helal Mohamed,  McLarty Jerry,  Williams Christopher R.,  Schreiber Fred James,  Parnes Howard,  Sebti Said,  Kazi Aslam,  Kang Loveleen,  Quinn Gwendolyn P.,  Smith Tiffany,  Yue Binglin,  Chornokur Ganna,  Crocker Theresa,  Schell Michael J.
J Clin Oncol 2015 May 20;33(15):Abstract 1572
PubMed ID: not available
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.

Kolesar JM,  Pomplun M,  Havighurst T,  Stublaski J,  Wollmer B,  Kim K,  Tangrea JA,  Parnes HL,  House MG,  Gee J,  Messing E,  Bailey HH
J Oncol Pharm Pract 2015 Apr;21(2):128-31
PubMed ID: 24642450
PMC ID: PMC4261043
Groups or Programs: Prostate and Urologic CancerPhase 0/I/II Trials

Association of NaF PET/CT findings with PSA and alkaline phosphatase in untreated castration-sensitive prostate cancer.

Couvillon Anna,  Turkbey Baris,  Lindenberg Maria Liza,  Choyke Peter L.,  Martinez Mirna,  McKinney Yolanda,  Kaushal Aradhana,  Citrin Deborah E.,  Krauze Andra,  McNally Deborah,  Giordano Luz,  Chun Guinevere,  Royce Cheryl,  Han Hui,  Karzai Fatima,  Parnes Howard L.,  Pinto Peter A.,  Gulley James L.,  Dahut William L.,  Madan Ravi Amrit
J Clin Oncol 2015 Mar 1;33(Suppl 7):Abstract 122
PubMed ID: not available
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Generalizability of established prostate cancer risk variants in men of African ancestry.

Han Y,  Signorello LB,  Strom SS,  Kittles RA,  Rybicki BA,  Stanford JL,  Goodman PJ,  Berndt SI,  Carpten J,  Casey G,  Chu L,  Conti DV,  Rand KA,  Diver WR,  Hennis AJ,  John EM,  Kibel AS,  Klein EA,  Kolb S,  Le Marchand L,  Leske MC,  Murphy AB,  Neslund-Dudas C,  Park JY,  Pettaway C,  Rebbeck TR,  Gapstur SM,  Zheng SL,  Wu SY,  Witte JS,  Xu J,  Isaacs W,  Ingles SA,  Hsing A,  PRACTICAL Consortium,  ELLIPSE GAME-ON Consortium,  Easton DF,  Eeles RA,  Schumacher FR,  Chanock S,  Nemesure B,  Blot WJ,  Stram DO,  Henderson BE,  Haiman CA
Int J Cancer 2015 Mar 1;136(5):1210-7
PubMed ID: 25044450
PMC ID: PMC4268262
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.

Hoque A,  Yao S,  Till C,  Kristal AR,  Goodman PJ,  Hsing AW,  Tangen CM,  Platz EA,  Stanczyk FZ,  Reichardt JK,  vanBokhoven A,  Neuhouser ML,  Santella RM,  Figg WD,  Price DK,  Parnes HL,  Lippman SM,  Ambrosone CB,  Thompson IM
Urology 2015 Mar;85(3):616-20
PubMed ID: 25733274
PMC ID: PMC4348556
Groups or Programs: Prostate and Urologic Cancer

Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

Zuo RC,  Apolo AB,  DiGiovanna JJ,  Parnes HL,  Keen CM,  Nanda S,  Dahut WL,  Cowen EW
JAMA Dermatol 2015 Feb;151(2):170-7
PubMed ID: 25427282
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Siddiqui MM,  Rais-Bahrami S,  Turkbey B,  George AK,  Rothwax J,  Shakir N,  Okoro C,  Raskolnikov D,  Parnes HL,  Linehan WM,  Merino MJ,  Simon RM,  Choyke PL,  Wood BJ,  Pinto PA
JAMA 2015 Jan 27;313(4):390-7
PubMed ID: 25626035
PMC ID: PMC4572575
Groups or Programs: Prostate and Urologic Cancer

Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Christen WG,  Glynn RJ,  Gaziano JM,  Darke AK,  Crowley JJ,  Goodman PJ,  Lippman SM,  Lad TE,  Bearden JD,  Goodman GE,  Minasian LM,  Thompson IM Jr,  Blanke CD,  Klein EA
JAMA Ophthalmol 2015 Jan;133(1):17-24
PubMed ID: 25232809
PMC ID: PMC4395006
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Chau CH,  Price DK,  Till C,  Goodman PJ,  Chen X,  Leach RJ,  Johnson-Pais TL,  Hsing AW,  Hoque A,  Tangen CM,  Chu L,  Parnes HL,  Schenk JM,  Reichardt JK,  Thompson IM,  Figg WD
PLoS One 2015;10(5):e0126672
PubMed ID: 25955319
PMC ID: PMC4425512
Groups or Programs: Prostate and Urologic Cancer

Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000).

Arnold KB,  Hermos JA,  Anderson KB,  Minasian L,  Tangen CM,  Probstfield JF,  Cook ED
Cancer Epidemiol Biomarkers Prev 2014 Dec;23(12):2895-905
PubMed ID: 25242051
PMC ID: PMC4257858
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?

Liang Y,  Ketchum NS,  Goodman PJ,  Klein EA,  Thompson IM Jr
J Urol 2014 Oct;192(4):1094-9
PubMed ID: 24747090
PMC ID: PMC4194238
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Albanes D,  Till C,  Klein EA,  Goodman PJ,  Mondul AM,  Weinstein SJ,  Taylor PR,  Parnes HL,  Gaziano JM,  Song X,  Fleshner NE,  Brown PH,  Meyskens FL Jr,  Thompson IM
Cancer Prev Res (Phila) 2014 Sep;7(9):886-95
PubMed ID: 24961880
PMC ID: PMC4408535
Groups or Programs: Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention Trials
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Crowe FL,  Appleby PN,  Travis RC,  Barnett M,  Brasky TM,  Bueno-de-Mesquita HB,  Chajes V,  Chavarro JE,  Chirlaque MD,  English DR,  Gibson RA,  Giles GG,  Goodman GE,  Henning SM,  Kaaks R,  King IB,  Kolonel LN,  Kristal AR,  Neuhouser ML,  Park SY,  Severi G,  Siddiq A,  Stampfer MJ,  Stattin P,  Tangen CM,  Tjønneland A,  Trichopoulos D,  Tumino R,  Wilkens LR,  Key TJ,  Allen NE,  Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group
J Natl Cancer Inst 2014 Sep;106(9)
PubMed ID: 25210201
PMC ID: PMC4188122
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT) ;  Selenium and Vitamin E Cancer Prevention Trial (SELECT)

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Martinez EE,  Darke AK,  Tangen CM,  Goodman PJ,  Fowke JH,  Klein EA,  Abdulkadir SA
Cancer Prev Res (Phila) 2014 Sep;7(9):950-7
PubMed ID: 24894197
PMC ID: PMC4154984
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Wolpin BM,  Rizzato C,  Kraft P,  Kooperberg C,  Petersen GM,  Wang Z,  Arslan AA,  Beane-Freeman L,  Bracci PM,  Buring J,  Canzian F,  Duell EJ,  Gallinger S,  Giles GG,  Goodman GE,  Goodman PJ,  Jacobs EJ,  Kamineni A,  Klein AP,  Kolonel LN,  Kulke MH,  Li D,  Malats N,  Olson SH,  Risch HA,  Sesso HD,  Visvanathan K,  White E,  Zheng W,  Abnet CC,  Albanes D,  Andreotti G,  Austin MA,  Barfield R,  Basso D,  Berndt SI,  Boutron-Ruault MC,  Brotzman M,  Büchler MW,  Bueno-de-Mesquita HB,  Bugert P,  Burdette L,  Campa D,  Caporaso NE,  Capurso G,  Chung C,  Cotterchio M,  Costello E,  Elena J,  Funel N,  Gaziano JM,  Giese NA,  Giovannucci EL,  Goggins M,  Gorman MJ,  Gross M,  Haiman CA,  Hassan M,  Helzlsouer KJ,  Henderson BE,  Holly EA,  Hu N,  Hunter DJ,  Innocenti F,  Jenab M,  Kaaks R,  Key TJ,  Khaw KT,  Klein EA,  Kogevinas M,  Krogh V,  Kupcinskas J,  Kurtz RC,  LaCroix A,  Landi MT,  Landi S,  Le Marchand L,  Mambrini A,  Mannisto S,  Milne RL,  Nakamura Y,  Oberg AL,  Owzar K,  Patel AV,  Peeters PH,  Peters U,  Pezzilli R,  Piepoli A,  Porta M,  Real FX,  Riboli E,  Rothman N,  Scarpa A,  Shu XO,  Silverman DT,  Soucek P,  Sund M,  Talar-Wojnarowska R,  Taylor PR,  Theodoropoulos GE,  Thornquist M,  Tjønneland A,  Tobias GS,  Trichopoulos D,  Vodicka P,  Wactawski-Wende J,  Wentzensen N,  Wu C,  Yu H,  Yu K,  Zeleniuch-Jacquotte A,  Hoover R,  Hartge P,  Fuchs C,  Chanock SJ,  Stolzenberg-Solomon RS,  Amundadottir LT
Nat Genet 2014 Sep;46(9):994-1000
PubMed ID: 25086665
PMC ID: PMC4191666
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Gritz ER,  Arnold KB,  Moinpour CM,  Burton-Chase AM,  Tangen CM,  Probstfield JF,  See WA,  Lieber MM,  Caggiano V,  Moody-Thomas S,  Szczepanek C,  Ryan A,  Carlin S,  Hill S,  Goodman PJ,  Padberg RM,  Minasian LM,  Meyskens FL,  Thompson IM Jr
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1638-48
PubMed ID: 25028457
PMC ID: PMC4119542
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director ;  Community Clinical Oncology Program (CCOP) ;  Prostate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.

Kristal AR,  Till C,  Song X,  Tangen CM,  Goodman PJ,  Neuhauser ML,  Schenk JM,  Thompson IM,  Meyskens FL Jr,  Goodman GE,  Minasian LM,  Parnes HL,  Klein EA
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1494-504
PubMed ID: 24732629
PMC ID: PMC4119495
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director ;  Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Statin drug use is not associated with prostate cancer risk in men who are regularly screened.

Platz EA,  Tangen CM,  Goodman PJ,  Till C,  Parnes HL,  Figg WD,  Albanes D,  Neuhouser ML,  Klein EA,  Lucia MS,  Thompson IM Jr,  Kristal AR
J Urol 2014 Aug;192(2):379-84
PubMed ID: 24518774
PMC ID: PMC4104140
Groups or Programs: Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention Trials
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.

Schenk JM,  Till CA,  Tangen CM,  Goodman PJ,  Song X,  Torkko KC,  Kristal AR,  Peters U,  Neuhouser ML
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1484-93
PubMed ID: 25085836
PMC ID: PMC4120235
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

Figg WD,  Chau CH,  Price DK,  Till C,  Goodman PJ,  Cho Y,  Varella-Garcia M,  Reichardt JK,  Tangen CM,  Leach RJ,  van Bokhoven A,  Thompson IM,  Lucia MS
Urology 2014 Jul;84(1):127-31
PubMed ID: 24824408
PMC ID: PMC4077907
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Ankerst DP,  Hoefler J,  Bock S,  Goodman PJ,  Vickers A,  Hernandez J,  Sokoll LJ,  Sanda MG,  Wei JT,  Leach RJ,  Thompson IM
Urology 2014 Jun;83(6):1362-7
PubMed ID: 24862395
PMC ID: PMC4035700
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Esserman LJ,  Thompson IM,  Reid B,  Nelson P,  Ransohoff DF,  Welch HG,  Hwang S,  Berry DA,  Kinzler KW,  Black WC,  Bissell M,  Parnes H,  Srivastava S
Lancet Oncol 2014 May;15(6):e234-42
PubMed ID: 24807866
PMC ID: PMC4322920
Groups or Programs: Cancer BiomarkersProstate and Urologic Cancer

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Gurel B,  Lucia MS,  Thompson IM Jr,  Goodman PJ,  Tangen CM,  Kristal AR,  Parnes HL,  Hoque A,  Lippman SM,  Sutcliffe S,  Peskoe SB,  Drake CG,  Nelson WG,  De Marzo AM,  Platz EA
Cancer Epidemiol Biomarkers Prev 2014 May;23(5):847-56
PubMed ID: 24748218
PMC ID: PMC4012292
Groups or Programs: Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention Trials
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

Kristal AR,  Darke AK,  Morris JS,  Tangen CM,  Goodman PJ,  Thompson IM,  Meyskens FL Jr,  Goodman GE,  Minasian LM,  Parnes HL,  Lippman SM,  Klein EA
J Natl Cancer Inst 2014 Mar;106(3):djt456
PubMed ID: 24563519
PMC ID: PMC3975165
Groups or Programs: Community Oncology and Prevention Trials ;  Office of the Director ;  Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial.

Pinsky PF,  Parnes HL,  Andriole G
BJU Int 2014 Feb;113(2):254-9
PubMed ID: 24053621
PMC ID: PMC3873374
Groups or Programs: Early DetectionProstate and Urologic Cancer

Phase III prostate cancer chemoprevention trials.

Parnes HL,  Brawley OW,  Minasian LM,  Ford LG
Recent Results Cancer Res 2014;202:73-7
PubMed ID: 24531780
PMC ID: not available
Groups or Programs: Office of the Director ;  Prostate and Urologic Cancer

Prostate cancer prevention: agent development strategies.

Parnes HL,  House MG,  Tangrea JA
Recent Results Cancer Res 2014;202:121-31
PubMed ID: 24531786
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Survival in the prostate cancer prevention trial.

Tangen CM,  Goodman PJ,  Thompson IM Jr
N Engl J Med 2013 Nov 14;369(20):1968
PubMed ID: 24224632
PMC ID: PMC4927191
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom score.

Ankerst DP,  Till C,  Boeck A,  Goodman PJ,  Tangen CM,  Thompson IM
Urology 2013 Nov;82(5):1076-81
PubMed ID: 24055241
PMC ID: PMC3874369
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.

Stamatakis L,  Siddiqui MM,  Nix JW,  Logan J,  Rais-Bahrami S,  Walton-Diaz A,  Hoang AN,  Vourganti S,  Truong H,  Shuch B,  Parnes HL,  Turkbey B,  Choyke PL,  Wood BJ,  Simon RM,  Pinto PA
Cancer 2013 Sep 15;119(18):3359-66
PubMed ID: 23821585
PMC ID: not available
Groups or Programs: Prostate and Urologic Cancer

Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?

Schenk JM,  Hunter-Merrill R,  Zheng Y,  Etzioni R,  Gulati R,  Tangen C,  Thompson IM,  Kristal AR
Am J Epidemiol 2013 Sep 1;178(5):741-51
PubMed ID: 23813705
PMC ID: PMC3755644
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Long-term survival of participants in the prostate cancer prevention trial.

Thompson IM Jr,  Goodman PJ,  Tangen CM,  Parnes HL,  Minasian LM,  Godley PA,  Lucia MS,  Ford LG
N Engl J Med 2013 Aug 15;369(7):603-10
PubMed ID: 23944298
PMC ID: PMC4141537
Groups or Programs: Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention Trials
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome.

Vickers AJ,  Sjoberg DD,  Ankerst DP,  Tangen CM,  Goodman PJ,  Thompson IM Jr
Cancer 2013 Aug 15;119(16):3007-11
PubMed ID: 23720006
PMC ID: PMC3735626
Groups or Programs: Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Brasky TM,  Darke AK,  Song X,  Tangen CM,  Goodman PJ,  Thompson IM,  Meyskens FL Jr,  Goodman GE,  Minasian LM,  Parnes HL,  Klein EA,  Kristal AR
J Natl Cancer Inst 2013 Aug 7;105(15):1132-41
PubMed ID: 23843441
PMC ID: PMC3735464
Groups or Programs: Prostate and Urologic Cancer ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention Trials
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)